The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
The p53/p63/p73 family of transcription factors: overlapping and distinct functions
Abstract
The p53 gene is the most frequently mutated gene in human cancer. The identification of two homologues, p63 and p73, revealed that p53 is a member of a family of related transcription factors. Given that they share amino acid sequence identity reaching 63% in the DNA-binding domain, p53, p63 and p73 should have redundant functions in the regulation of gene expression. Indeed, p73 can activate p53-regulated genes and suppress growth or induce apoptosis. Moreover, p53 and p73 are both induced by DNA damage – albeit through distinct mechanisms. Other evidence, however, suggests that p63 and p73 are important for regulation of normal development. An extended C-terminal region, not found in p53, is alternatively spliced in p63 and p73. Within this C-terminal extension is a sterile alpha motif (SAM) previously found in other proteins that regulate development. The p63-deficient mice showed developmental abnormalities. Interestingly, the human p63 gene is mutated in children who have the disease Ectrodactyly, Ectodermal dysplasia and facial Clefts (EEC) syndrome, and the disease phenotype is similar to the one of p63-deficient mice. The p63 and p73 genes are rarely mutated in human cancer, although p73 loss is observed in neuroblastoma and a subtype of T-cell lymphoma. p53, p63 and p73 appear to have overlapping and distinct functions: p53 regulates the stress response to suppress tumors; p63 is essential for ectoderm development; and p73 might regulate both the stress response and development. Because p53 and p73 are linked to different upstream pathways, this family of transcription factors might regulate a common set of genes in response to different extracellular signals and developmental cues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development
Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R. T., Tabin, C., Sharpe, A., Caput, D., Crum, C., et al. (1999) · Nature · doi:10.1038/19539 · Cited by 2,225
Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M. D., Dötsch, V., Andrews, N. C., Caput, D., & McKeon, F. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80275-0 · Cited by 2,085
p63 is a p53 homologue required for limb and epidermal morphogenesis
Mills, A. A., Zheng, B., Wang, X.-J., Vogel, H., Roop, D. R., & Bradley, A. (1999) · Nature · doi:10.1038/19531 · Cited by 1,988
Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J.-C., Valent, A., Minty, A., Chalon, P., Lelias, J.-M., Dumont, X., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80540-1 · Cited by 1,637
The complexity of p53 modulation: emerging patterns from divergent signals
Giaccia, A. J., & Kastan, M. B. (1998) · Genes & Development · doi:10.1101/gad.12.19.2973 · Cited by 1,314
Yang, A., Walker, N., Bronson, R., Kaghad, M., Oosterwegel, M., Bonnin, J., Vagner, C., Bonnet, H., Dikkes, P., Sharpe, A., et al. (2000) · Nature · doi:10.1038/35003607 · Cited by 990
p73 is a human p53-related protein that can induce apoptosis
Jost, C. A., Marin, M. C., & Jr, W. G. K. (1997) · Nature · doi:10.1038/38298 · Cited by 948
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage
Gong, J., Costanzo, A., Yang, H.-Q., Melino, G., Kaelin, W. G., Levrero, M., & Wang, J. Y. J. (1999) · Nature · doi:10.1038/21690 · Cited by 930
Self-citationRegulation ofp53downstream genes
El-Deiry, W. S. (1998) · Seminars in Cancer Biology · doi:10.1006/scbi.1998.0097 · Cited by 800
Heterozygous Germline Mutations in the p53 Homolog p63 Are the Cause of EEC Syndrome
Celli, J., Duijf, P., Hamel, B. C. J., Bamshad, M., Kramer, B., Smits, A. P. T., Newbury-Ecob, R., Hennekam, R. C. M., Van Buggenhout, G., van Haeringen, A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81646-3 · Cited by 713
p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage
Yuan, Z.-M., Shioya, H., Ishiko, T., Sun, X., Gu, J., Huang, Y., Lu, H., Kharbanda, S., Weichselbaum, R., & Kufe, D. (1999) · Nature · doi:10.1038/21704 · Cited by 578
Regulation of the p53 Tumor Suppressor Protein
Oren, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36031 · Cited by 564
Interaction of c-Abl and p73α and their collaboration to induce apoptosis
Agami, R., Blandino, G., Oren, M., & Shaul, Y. (1999) · Nature · doi:10.1038/21697 · Cited by 546
P19 ARF stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2
Tao, W., & Levine, A. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6937 · Cited by 540
Baskaran, R., Wood, L. D., Whitaker, L. L., Canman, C. E., Morgan, S. E., Xu, Y., Barlow, C., Baltimore, D., Wynshaw-Boris, A., Kastan, M. B., et al. (1997) · Nature · doi:10.1038/387516a0 · Cited by 539
Self-citationCloning and functional analysis of human p51, which structurally and functionally resembles p53
Osada, M., Ohba, M., Kawahara, C., Ishioka, C., Kanamaru, R., Katoh, I., Ikawa, Y., Nimura, Y., Nakagawara, A., Obinata, M., et al. (1998) · Nature Medicine · doi:10.1038/nm0798-839 · Cited by 529
Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation
Hollstein, M. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.1.141 · Cited by 499
Identification and classification of p53-regulated genes
Yu, J., Zhang, L., Hwang, P. M., Rago, C., Kinzler, K. W., & Vogelstein, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14517 · Cited by 452
Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress
Amundson, S. A., Myers, T. G., & Fornace, A. J. (1998) · Oncogene · doi:10.1038/sj.onc.1202576 · Cited by 424
p73 Function Is Inhibited by Tumor-Derived p53 Mutants in Mammalian Cells
Di Como, C. J., Gaiddon, C., & Prives, C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1438 · Cited by 417
Two New p73 Splice Variants, γ and δ, with Different Transcriptional Activity
De Laurenzi, V., Costanzo, A., Barcaroli, D., Terrinoni, A., Falco, M., Annicchiarico-Petruzzelli, M., Levrero, M., & Melino, G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1763 · Cited by 368
Self-citationThree distinct signalling responses by murine fibroblasts to genotoxic stress
Liu, Z.-G., Baskaran, R., Lea-Chou, E. T., Wood, L. D., Chen, Y., Karin, M., & Wang, J. Y. J. (1996) · Nature · doi:10.1038/384273a0 · Cited by 355
Self-citationZhang, Y., & Xiong, Y. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80351-2 · Cited by 348
MDM2 suppresses p73 function without promoting p73 degradation
Zeng, X., Chen, L., Jost, C. A., Maya, R., Keller, D., Wang, X., Kaelin, W. G., Oren, M., Chen, J., & Lu, H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3257 · Cited by 334
The potential tumor suppressor p73 differentially regulates cellular p53 target genes.
Zhu, J., Jiang, J., Zhou, W., & Chen, X. (1998) · PubMed · Cited by 324
Blockage by Adenovirus E4orf6 of Transcriptional Activation by the p53 Tumor Suppressor
Dobner, T., Horikoshi, N., Rubenwolf, S., & Shenk, T. (1996) · Science · doi:10.1126/science.272.5267.1470 · Cited by 311
Gottlieb, T. M., & Oren, M. (1998) · Seminars in Cancer Biology · doi:10.1006/scbi.1998.0098 · Cited by 297
Donehower, L. A., Godley, L. A., Aldaz, C. M., Pyle, R., Shi, Y. P., Pinkel, D., Gray, J., Bradley, A., Medina, D., & Varmus, H. E. (1995) · Genes & Development · doi:10.1101/gad.9.7.882 · Cited by 276
Mdm2 binds p73α without targeting degradation
Bálint, E., Bates, S., & Vousden, K. H. (1999) · Oncogene · doi:10.1038/sj.onc.1202781 · Cited by 212
Viral Oncoproteins Discriminate between p53 and the p53 Homolog p73
Marin, M. C., Jost, C. A., Irwin, M. S., DeCaprio, J. A., Caput, D., & Kaelin, W. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6316 · Cited by 193
Overexpression of the wild type p73 gene in breast cancer tissues and cell lines.
Zaika, A., Kovalev, S. Y., Marchenko, N. D., & Moll, U. M. (1999) · PubMed · Cited by 191
Induction of Neuronal Differentiation by p73 in a Neuroblastoma Cell Line
De Laurenzi, V., Raschellá, G., Barcaroli, D., Annicchiarico-Petruzzelli, M., Ranalli, M., Catani, M. V., Tanno, B., Costanzo, A., Levrero, M., & Melino, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.15226 · Cited by 184
Self-citationNomoto, S., Haruki, N., Kondo, M., Konishi, H., Takahashi, T., Takahashi, T., & Takahashi, T. (1998) · PubMed · Cited by 175
Promoter specificity and stability control of the p53-related protein p73
Lee, C., & Thangue, N. B. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202793 · Cited by 170
Chi, S.-W. (1999) · The EMBO Journal · doi:10.1093/emboj/18.16.4438 · Cited by 169
New p73 variants with altered C-terminal structures have varied transcriptional activities
Ueda, Y., Hijikata, M., Takagi, S., Chiba, T., & Shimotohno, K. (1999) · Oncogene · doi:10.1038/sj.onc.1202817 · Cited by 163
Expression of p73 and Its Relation to Histopathology and Prognosis in Hepatocellular Carcinoma
Tannapfel, A., Wasner, M., Krause, K., Geissler, F., Katalinic, A., Hauss, J., Mossner, J., Engeland, K., & Wittekind, C. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.13.1154 · Cited by 163
Davison, T. S., Vagner, C., Kaghad, M., Ayed, A., Caput, D., & Arrowsmith, C. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18709 · Cited by 160
Laurenzi, V. D., Catani, M., Costanzo, A., Terrinoni, A., Corazzari, M., Levrero, M., Knight, R. A., & Melino, G. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400521 · Cited by 160
Self-citationp53 family genes: structural comparison, expression and mutation
Ikawa, S., Nakagawara, A., & Ikawa, Y. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400631 · Cited by 150
Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma.
Takahashi, H., Ichimiya, S., Nimura, Y., Watanabe, M., Furusato, M., Wakui, S., Yatani, R., Aizawa, S., & Nakagawara, A. (1998) · PubMed · Cited by 142
c-Abl: activation and nuclear targets
Shaul, Y. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400626 · Cited by 139
Overexpression of the wild type p73 gene in human bladder cancer
Yokomizo, A., Mai, M., Tindall, D. J., Liang Cheng, C., Bostwick, D. G., Naito, S., Smith, D. I., & Liu, W. (1999) · Oncogene · doi:10.1038/sj.onc.1202474 · Cited by 139
Roth, J. C., König, C., Wienzek‐Lischka, S., Weigel, S., Ristea, S., & Dobbelstein, M. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8510-8516.1998 · Cited by 134
MDM2 and MDMX bind and stabilize the p53-related protein p73
Ongkeko, W. M., Wang, X. Q., Siu, W. Y., Lau, A. W. S., Yamashita, K., Harris, A. L., Cox, L. S., & Poon, R. Y. C. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80367-4 · Cited by 134
Kovalev, S., Marchenko, N. D., Swendeman, S. L., LaQuaglia, M. P., & Moll, U. M. (1998) · PubMed · Cited by 131
Structure, function and regulation of p63 and p73
Levrero, M., Laurenzi, V. D., Costanzo, A., Gong, J., Melino, G., & Wang, J. Y. J. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400624 · Cited by 123
Self-citationp73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent
Ichimiya, S., Nimura, Y., Kageyama, H., Takada, N., Sunahara, M., Shishikura, T., Nakamura, Y., Sakiyama, S., Seki, N., Ohira, M., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202390 · Cited by 120
Structure and function in the p53 family
Arrowsmith, C. H. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400619 · Cited by 119
Regulation and activation of p53 and its family members
Lohrum, M. A. E., & Vousden, K. H. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400625 · Cited by 102
Zeng, X., Li, X., Miller, A., Yuan, Z.-M., Yuan, W., Kwok, R. P. S., Goodman, R. H., & Lu, H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1299-1310.2000 · Cited by 101
Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas.
Sunahara, M., Ichimiya, S., Nimura, Y., Takada, N., Sakiyama, S., Satō, Y., Todo, S., Adachi, W., Amano, J., & Nakagawara, A. (1998) · International Journal of Oncology · doi:10.3892/ijo.13.2.319 · Cited by 96
Distinct Regulation of p53 and p73 Activity by Adenovirus E1A, E1B, and E4orf6 Proteins
Steegenga, W. T., Shvarts, A., Riteco, N., Bos, J. L., & Jochemsen, A. G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3885 · Cited by 93
The large T antigen of simian virus 40 binds and inactivates p53 but not p73.
Dobbelstein, M., & Roth, J. A. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-12-3079 · Cited by 83
p73, a geme related top53, is not mutated in esophageal carcinomas
Nimura, Y., Mihara, M., Ichimiya, S., Sakiyama, S., Seki, N., Ohira, M., Nomura, N., Fujimori, M., Adachi, W., Amano, J., et al. (1998) · International Journal of Cancer · Cited by 78
Infrequent somatic mutations of thep73genein various human cancers
Han, S., Semba, S., Abe, T., Makino, N., Furukawa, T., Fukushige, S., Takahashi, H., Sakurada, A., Sato, M., Shiiba, K.-I., et al. (1999) · European Journal of Surgical Oncology · doi:10.1053/ejso.1998.0626 · Cited by 78
Loss of imprinting and allele switching of p73 in renal cell carcinoma
Mai, M., Qian, C., Yokomizo, A., Tindall, D. J., Bostwick, D. G., Polychronakos, C., Smith, D. I., & Liu, W. (1998) · Oncogene · doi:10.1038/sj.onc.1202099 · Cited by 77
Prabhu, N. S., Somasundaram, K., Satyamoorthy, K., Herlyn, M., & El‐Deiry, W. S. (1998) · International Journal of Oncology · doi:10.3892/ijo.13.1.5 · Cited by 73
Tannapfel, A., Engeland, K., Weinans, L., Katalinic, A., Hauss, J., Mössner, J., & Wittekind, C. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690465 · Cited by 62
Accelerated neuronal differentiation induced by p53 suppression
Ferreira, A., & Kosik, K. S. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.6.1509 · Cited by 61
Astronomers Tame a Workhorse Laser
Watson, A. (1996) · Science · doi:10.1126/science.274.5292.1470 · Cited by 56
Adenovirus E4orf6 oncoprotein modulates the function of the p53-related protein, p73
Higashino, F., Pipas, J. M., & Shenk, T. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15683 · Cited by 54
Apoptosis and the cell cycle: the p53 connection
Choisy, C., & Yonish-Rouach, E. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400339 · Cited by 51
Yokozaki, H., Shitara, Y., Fujimoto, J.-Y., Hiyama, T., Yasui, W., & Tahara, E. (1999) · International Journal of Cancer · Cited by 48
Takada, N., Ozaki, T., Ichimiya, S., Todo, S., & Nakagawara, A. (1999) · PubMed · Cited by 42
Different p73 splicing variants are expressed in distinct tumour areas of a multifocal neuroblastoma
Casciano, I., Ponzoni, M., Cunsolo, C., et al. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400522 · Cited by 39
Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma
Mihara, M., Nimura, Y., Ichimiya, S., Sakiyama, S., Kajikawa, S., Adachi, W., Amano, J., & Nakagawara, A. (1998) · British Journal of Cancer · doi:10.1038/sj.bjc.6690027 · Cited by 37
Ding, Y. (1999) · DNA Research · doi:10.1093/dnares/6.5.347 · Cited by 37
Ejeskär, K., Sjöberg, R. M., Kogner, P., et al. (1999) · International Journal of Molecular Medicine · doi:10.3892/ijmm.3.6.585 · Cited by 18
Cellular senescence and cancer
(1999) · doi:10.1002/(sici)1096-9896(199901)187:1
Cited by
Inhibiting the p53–MDM2 interaction: an important target for cancer therapy
Chène, P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc991 · Cited by 765
p73: Friend or foe in tumorigenesis
Melino, G., De Laurenzi, V., & Vousden, K. H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc861 · Cited by 560
Self-citationp53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug
Wang, S.-P., Wang, W.-L., Chang, Y.-L., Wu, C.-T., Chao, Y.-C., Kao, S.-H., Yuan, A., Lin, C.-W., Yang, S.-C., Chan, W.-K., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1875 · Cited by 493
BCL-2 protein family: attractive targets for cancer therapy
Kaloni, D., Diepstraten, S. T., Strasser, A., & Kelly, G. L. (2023) · Apoptosis · doi:10.1007/s10495-022-01780-7 · Cited by 500
p63 and p73: p53 mimics, menaces and more
Yang, A., & McKeon, F. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043127 · Cited by 483
Metadata
- Authors
- Levrero, M., Laurenzi, V. D., Costanzo, A., Sabatini, S., Gong, J., Wang, J. Y. J., & Melino, G.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2000-05-15
- Volume
- 113
- Issue
- 10
- Pages
- 1661-1670
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W1937707692
- Cited by
- 565
- References
- 76
- FWCI
- 15.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.